AKITA Inhaled Steroid Suspension for Inhalation (AICS) in Subjects With Asthma
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The goal of treatment with AICS is weaning from oral corticosteroids, i.e. a reduction of the
oral corticosteroid dose. An anticipated treatment benefit of AICS is a reduction of oral
corticosteroid dose and stability/improvement of clinical parameters related to asthma in the
targeted subject population. Ultimately, the goal is to free subjects with severe asthma from
the burden of chronic oral steroid therapy.